• 1 November 2011

    Pfizer acquires Icagen

    Pfizer, through its wholly owned subsidiary Eclipse Acquisition, has completed the acquisition of biopharmaceutical company Icagen.

  • 1 November 2011

    FDA clears Vegenics VGX-100 drug trial

    The US Food and Drug Administration (FDA) has approved an investigational new drug application from Vegenics, a subsidiary of Circadian Technologies, to commence clinical trials of VGX-100 for the treatment...

  • 31 October 2011

    FDA approves Mylan pain drug

    Mylan's abbreviated new drug application for morphine sulphate extended-release tablets has been approved by the US Food and Drug Administration (FDA) .

  • 30 October 2011

    Bionovo commences Menerba drug Phase 3 trial

    Biotech company Bionovo has begun a Phase 3 clinical trial designed to assess the safety and efficacy of two doses of oral estrogen receptor beta (ER-b) selective drug, Menerba (MF101),...


Go Top